Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome.
about
Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley FeverHemorrhagic Fever with Renal Syndrome: Pathogenesis and Clinical PictureAnimal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and HantavirusesPre-symptomatic diagnosis and treatment of filovirus diseasesAntiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposureEvaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic feverCompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusEfficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome VirusHemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.Ebola Virus Infection: Overview and Update on Prevention and Treatment.Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever virusesAntiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters.Ribavirin protects Syrian hamsters against lethal hantavirus pulmonary syndrome--after intranasal exposure to Andes virusFavipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.Potential and emerging treatment options for Ebola virus disease.Extinction of West Nile virus by Favipiravir through lethal mutagenesis.Landscape, Climate and Hantavirus Cardiopulmonary Syndrome Outbreaks.Understanding the Mechanism of the Broad-Spectrum Antiviral Activity of Favipiravir (T-705): Key Role of the F1 Motif of the Viral Polymerase.A lethal disease model for New World hantaviruses using immunosuppressed Syrian hamsters.Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.Lentivirus Expression of Hantavirus Nucleocapsid Proteins
P2860
Q21092271-2C060ACC-AF10-48A6-B20A-B4AD087E0606Q26766338-A67D7588-730E-4794-BF45-49907C20867AQ26798695-BBA4D31D-D490-4330-8D7D-165C385552C6Q26823831-D96CBBB4-E23F-4189-A38C-9CC6F306BD53Q27304441-708BCA7E-74FA-4D22-8DA1-0EB98DC46957Q27457152-094DECDA-ED11-4B1A-863C-6B5941B8829DQ28084005-4B35C927-648D-4CAC-B568-CE27D2130E7EQ33433096-9F5DCEF7-688D-4303-922F-E3E0F17B3208Q33439713-B30C0E93-50DE-4C21-B00C-65BBEFF25CE7Q36146469-A9AC7029-407E-4888-AFC4-6C747E923F31Q36166222-7819639B-9EB2-4A9D-84F3-B0D5735E9EECQ36363253-A927E34F-6EC9-4863-99FC-3169C7A2DFE7Q36494323-16CC957D-F0F0-4918-BFC9-092A566656CDQ37120083-54648253-9CC5-4ABE-AC40-7DD621EC47A3Q37376384-B3B6EF6B-2BC3-4303-864E-09F0DFE8D582Q37683496-3BD36F1D-B240-4DDB-99C6-28E764728BBDQ38270149-CF2B2F9D-EDA6-4492-A84E-903210FA7AF0Q38605122-5CD6C9D9-7FBF-4885-9F8C-02BCD7C2984CQ38670381-D93D77BB-2C55-455F-9896-DD091560A2CFQ40255981-628DB3B7-6D28-4EC1-A90F-BE3508AD9819Q43167931-D1992C3A-8A9E-48AC-BA67-6F1399940833Q45324172-C7234DD4-8E3D-4E29-BF48-010E8E7FBC35Q58051830-C01B8310-3927-4894-ADAD-08AFD385CFD7
P2860
Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiviral efficacy of favipira ...... hantavirus pulmonary syndrome.
@en
Antiviral efficacy of favipira ...... hantavirus pulmonary syndrome.
@nl
type
label
Antiviral efficacy of favipira ...... hantavirus pulmonary syndrome.
@en
Antiviral efficacy of favipira ...... hantavirus pulmonary syndrome.
@nl
prefLabel
Antiviral efficacy of favipira ...... hantavirus pulmonary syndrome.
@en
Antiviral efficacy of favipira ...... hantavirus pulmonary syndrome.
@nl
P2093
P2860
P50
P356
P1476
Antiviral efficacy of favipira ...... hantavirus pulmonary syndrome.
@en
P2093
Brian B Gowen
Dana P Scott
Yousuke Furuta
P2860
P304
P356
10.1128/AAC.00886-13
P407
P577
2013-07-15T00:00:00Z